Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAK-041 for motivational anhedonia in schizophrenia
NCT03319953Phase 2Completed
- Sponsor
- Neurocrine Biosciences
- Start
- Dec 2017
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of zelatriazin in schizophrenia, sponsored by Neurocrine Biosciences. Started Dec 2017; status: completed.
02
Drugs
zelatriazin
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT03319953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03319953.